Randomized study of the effect of pentoxifylline or octreotide on serum levels of TNF-α and IL-6 after endoscopic retrograde cholangiopancreatography

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 5, 2009, Pages 529-533

  Kapetanos, Dimitrios ^a   Christodoulou, Dimitrios ^b   Chatzizisi, Olga ^c   Sigounas, Dimitrios ^b   Vasiliou, Konstantinos ^a   Stavropoulou, Electra ^c   Katodritou, Eirini ^a   Kokozidis, Georgios ^a   Kiriazis, Georgios ^c   Kitis, Georgios ^a   Tsianos, Epaminondas ^b  

^a G PAPANICOLAOU HOSPITAL   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Endoscopic retrograde cholangiopancreatography; IL 6; Octreotide; Pancreatitis; Pentoxifylline; TNF alpha

Indexed keywords

INTERLEUKIN 6; OCTREOTIDE; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; PANCREATITIS; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL;

ACUTE DISEASE; ADULT; AGED; BIOLOGICAL MARKERS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; OCTREOTIDE; PANCREATITIS; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67651172836     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32831ac93a     Document Type: Article

References (30)

1. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, et al. Pathophysiology of acute pancreatitis. Pancreatology 2005; 5:132-144. Epub 21 April 2005.
2. Grewal HP, Kotb M, el Din AM, Ohman M, Salem A, Gaber L, et al. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 1994; 115:213-221.
3. Hughes CB, Gaber LW, Kotb M, Mohey el-Din AB, Pabst M, Gaber AO. Induction of acute pancreatitis in germ-free rats: evidence of a primary role for tumor necrosis factor-alpha. Surgery 1995; 117:201-205.
4. Osman MO, Gesser B, Mortensen JT, Matsushima K, Jensen SL, Larsen CG. Profiles of pro-inflammatory cytokines in the serum of rabbits after experimentally induced acute pancreatitis. Cytokine 2002; 17:53-59. (Pubitemid 34925856)
5. Vaccaro MI, Ropolo A, Grasso D, Calvo EL, Ferreria M, Iovanna JL, et al. Pancreatic acinar cells submitted to stress activate TNF-alpha gene expression. Biochem Biophys Res Commun 2000; 268:485-490. (Pubitemid 30119649)
6. Doherty GM, Jensen JC, Alexander HR, Buresh CM, Norton JA. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 1991; 110:192-198.
7. Matheus A, Coelho A, Sampietre S, Morioka C, Jukemura J, Cunha J, et al. Pentoxifylline reduce inflammatory mediators levels and mortality rate in an experimental acute pancreatitis model. Pancreas 2004; 29:366.
8. Zabel P, Schade FU, Schlaak M. Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 1993; 187:447-463. (Pubitemid 23150784)
9. Li ZS, Pan X, Zhang WJ, Gong B, Zhi FC, Guo XG, et al. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: a multicenter, placebo-controlled, randomized clinical trial. Am J Gastroenterol 2007; 102:46-51. (Pubitemid 46072042)
10. Thomopoulos KC, Pagoni NA, Vagenas KA, Margaritis VG, Theocharis GI, Nikolopoulou VN. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Gastrointest Endosc 2006; 64:726-731.
11. Chen CC, Wang SS, Lu RH, Lu CC, Chang FY, Lee SD. Early changes of serum proinflammatory and anti-inflammatory cytokines after endoscopic retrograde cholangiopancreatography. Pancreas 2003; 26:375-380.
12. Deviere J, Le Moine O, Van Laethem JL, Eisendrath P, Ghilain A, Severs N, et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001; 120:498-505. (Pubitemid 32147647)
13. Kaw M, Singh S. Serum lipase, C-reactive protein, and interleukin-6 levels in ERCP-induced pancreatitis. Gastrointest Endosc 2001; 54:435-440.
14. Messmann H, Vogt W, Falk W, Vogl D, Zirngibl H, Leser HG, et al. Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis. Eur J Gastroenterol Hepatol 1998; 10:611-617. (Pubitemid 28330611)
15. Messmann H, Vogt W, Holstege A, Lock G, Heinisch A, von Furstenberg A, et al. Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut 1997; 40:80-85. (Pubitemid 27079755)
16. Oezcueruemez-Porsch M, Kunz D, Hardt PD, Fadgyas T, Kress O, Schulz HU, et al. Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Dig Dis Sci 1998; 43:1763-1769. (Pubitemid 28381589)
17. Petersson U, Borgstrom A, Ohlsson K, Fork FT, Toth E. Enzyme leakage, trypsinogen activation, and inflammatory response in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Pancreas 2002; 24: 321-328. (Pubitemid 34441911)
18. Pezzilli R, Gabbrielli A, Labate AM, D'Alessio P, Barakat B, Costamagna G, et al. Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination? Hepatogastroenterology 2003; 50:851-855.
19. Wozniak B, Wisniewska-Jarosinska M, Drzewoski J. Evaluation of selected parameters of the inflammatory response to endoscopic retrograde cholangiopancreatography. Pancreas 2001; 23:349-355. (Pubitemid 32983291)
20. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37:383-393.
21. Norman J, Franz M, Messina J, Riker A, Fabri PJ, Rosemurgy AS, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995; 117:648-655.
22. Gomez-Cambronero L, Camps B, de La Asuncion JG, Cerda M, Pellin A, Pallardo FV, et al. Pentoxifylline ameliorates cerulein-induced pancreatitis in rats: role of glutathione and nitric oxide. J Pharmacol Exp Ther 2000; 293:670-676. (Pubitemid 30244122)
23. Marton J, Szasz Z, Nagy Z, Jarmay K, Takacs T, Lonovics J, et al. Beneficial effect of octreotide treatment in acute pancreatitis in rats. Int J Pancreatol 1998; 24:203-210. (Pubitemid 29011221)
24. Pereda J, Sabater L, Cassinello N, Gomez-Cambronero L, Closa D, Folch-Puy E, et al. Effect of simultaneous inhibition of TNF-alpha production and xanthine oxidase in experimental acute pancreatitis: the role of mitogen activated protein kinases. Ann Surg 2004; 240:108-116. (Pubitemid 38808242)
25. Folch E, Serrano A, Sabater L, Gelpi E, Rosello-Catafau J, Closa D. Soluble receptors released during acute pancreatitis interfere with the detection of tumor necrosis factor-alpha. Crit Care Med 2001; 29:1023-1026. (Pubitemid 32424357)
26. Czako L, Hegyi P, Takacs T, Gog C, Farkas A, Mandy Y, et al. Effects of octreotide on acute necrotizing pancreatitis in rabbits. World J Gastroenterol 2004; 10:2082-2086. (Pubitemid 39106963)
27. Zhang XP, Zhang L, He JX, Zhang RP, Cheng QH, Zhou YF, et al. Experimental study of therapeutic efficacy of Baicalin in rats with severe acute pancreatitis. World J Gastroenterol 2007; 13:717-724. (Pubitemid 46252393)
28. Kapetanos D, Kokozidis G, Christodoulou D, Mistakidis K, Sigounas D, Dimakopoulos K, et al. A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis. Gastrointest Endosc 2007; 66: 513-518. (Pubitemid 47304417)
29. Sebba A. Tocilizumab: the first interleukin-6-receptor inhibitor. Am J Health Syst Pharm 2008; 65:1413-1418.
30. Adachi Y, Yoshio-Hoshino N, Nishimoto N. The Blockade of IL-6 signaling in rational drug design. Curr Pharm Des 2008; 14:1217-1224. (Pubitemid 351997834)